▶ 調査レポート

世界のラジオイムノアッセイ市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Radioimmunoassays Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のラジオイムノアッセイ市場規模・現状・予測(2021年-2027年) / Global Radioimmunoassays Market Size, Status and Forecast 2021-2027 / QYR2104Z4910資料のイメージです。• レポートコード:QYR2104Z4910
• 出版社/出版日:QYResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、129ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、ラジオイムノアッセイのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(バランス法、連続飽和法)、用途別市場規模(製薬、医療検査、腫瘍、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・ラジオイムノアッセイの市場動向
・企業の競争状況、市場シェア
・ラジオイムノアッセイの種類別市場規模(バランス法、連続飽和法)
・ラジオイムノアッセイの用途別市場規模(製薬、医療検査、腫瘍、その他)
・ラジオイムノアッセイの北米市場規模2016-2027(アメリカ、カナダ)
・ラジオイムノアッセイのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・ラジオイムノアッセイのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ラジオイムノアッセイの中南米市場規模2016-2027(メキシコ、ブラジル)
・ラジオイムノアッセイの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Immunoshop India Pvt Ltd.、Institute Of Isotopes Co. Ltd、Instrumentation Laboratory Co.、Novartis Vaccines & Diagnostics Inc.、Sysmex、Trinity Biotech Plc、Weifang 3v Bioengineering Group Co. Ltd.、Weifang Kanghua Biotech Co. Ltd.、Abbott Diagnostics、Acon Laboratories Inc.、Amar Immunodiagnostics、Bayer Ag、Beckman Coulter Inc.、Xiamen Boson Biotech Co. Ltd.、Jei Daniel Biotech Corp.、Labor Diagnostika Nord Gmbh & Co. Kg、Micropoint Bioscience Inc.)
・結論

Market Analysis and Insights: Global Radioimmunoassays Market
The global Radioimmunoassays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radioimmunoassays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radioimmunoassays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radioimmunoassays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radioimmunoassays market.

Global Radioimmunoassays Scope and Market Size
Radioimmunoassays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radioimmunoassays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Balance Method
Sequential Saturation Method

Segment by Application
Pharmaceutical
Medical Testing
Onology
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Immunoshop India Pvt Ltd.
Institute Of Isotopes Co. Ltd
Instrumentation Laboratory Co.
Novartis Vaccines & Diagnostics Inc.
Sysmex
Trinity Biotech Plc
Weifang 3v Bioengineering Group Co. Ltd.
Weifang Kanghua Biotech Co. Ltd.
Abbott Diagnostics
Novartis Vaccines & Diagnostics Inc.
Sysmex
Bayer Ag
Beckman Coulter Inc.
Xiamen Boson Biotech Co. Ltd.
Jei Daniel Biotech Corp.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioimmunoassays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Balance Method
1.2.3 Sequential Saturation Method
1.3 Market by Application
1.3.1 Global Radioimmunoassays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Medical Testing
1.3.4 Onology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Radioimmunoassays Market Perspective (2016-2027)
2.2 Radioimmunoassays Growth Trends by Regions
2.2.1 Radioimmunoassays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Radioimmunoassays Historic Market Share by Regions (2016-2021)
2.2.3 Radioimmunoassays Forecasted Market Size by Regions (2022-2027)
2.3 Radioimmunoassays Industry Dynamic
2.3.1 Radioimmunoassays Market Trends
2.3.2 Radioimmunoassays Market Drivers
2.3.3 Radioimmunoassays Market Challenges
2.3.4 Radioimmunoassays Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Radioimmunoassays Players by Revenue
3.1.1 Global Top Radioimmunoassays Players by Revenue (2016-2021)
3.1.2 Global Radioimmunoassays Revenue Market Share by Players (2016-2021)
3.2 Global Radioimmunoassays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Radioimmunoassays Revenue
3.4 Global Radioimmunoassays Market Concentration Ratio
3.4.1 Global Radioimmunoassays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioimmunoassays Revenue in 2020
3.5 Radioimmunoassays Key Players Head office and Area Served
3.6 Key Players Radioimmunoassays Product Solution and Service
3.7 Date of Enter into Radioimmunoassays Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Radioimmunoassays Breakdown Data by Type
4.1 Global Radioimmunoassays Historic Market Size by Type (2016-2021)
4.2 Global Radioimmunoassays Forecasted Market Size by Type (2022-2027)

5 Radioimmunoassays Breakdown Data by Application
5.1 Global Radioimmunoassays Historic Market Size by Application (2016-2021)
5.2 Global Radioimmunoassays Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Radioimmunoassays Market Size (2016-2027)
6.2 North America Radioimmunoassays Market Size by Type
6.2.1 North America Radioimmunoassays Market Size by Type (2016-2021)
6.2.2 North America Radioimmunoassays Market Size by Type (2022-2027)
6.2.3 North America Radioimmunoassays Market Size by Type (2016-2027)
6.3 North America Radioimmunoassays Market Size by Application
6.3.1 North America Radioimmunoassays Market Size by Application (2016-2021)
6.3.2 North America Radioimmunoassays Market Size by Application (2022-2027)
6.3.3 North America Radioimmunoassays Market Size by Application (2016-2027)
6.4 North America Radioimmunoassays Market Size by Country
6.4.1 North America Radioimmunoassays Market Size by Country (2016-2021)
6.4.2 North America Radioimmunoassays Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Radioimmunoassays Market Size (2016-2027)
7.2 Europe Radioimmunoassays Market Size by Type
7.2.1 Europe Radioimmunoassays Market Size by Type (2016-2021)
7.2.2 Europe Radioimmunoassays Market Size by Type (2022-2027)
7.2.3 Europe Radioimmunoassays Market Size by Type (2016-2027)
7.3 Europe Radioimmunoassays Market Size by Application
7.3.1 Europe Radioimmunoassays Market Size by Application (2016-2021)
7.3.2 Europe Radioimmunoassays Market Size by Application (2022-2027)
7.3.3 Europe Radioimmunoassays Market Size by Application (2016-2027)
7.4 Europe Radioimmunoassays Market Size by Country
7.4.1 Europe Radioimmunoassays Market Size by Country (2016-2021)
7.4.2 Europe Radioimmunoassays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Radioimmunoassays Market Size (2016-2027)
8.2 Asia-Pacific Radioimmunoassays Market Size by Type
8.2.1 Asia-Pacific Radioimmunoassays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Radioimmunoassays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Radioimmunoassays Market Size by Type (2016-2027)
8.3 Asia-Pacific Radioimmunoassays Market Size by Application
8.3.1 Asia-Pacific Radioimmunoassays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Radioimmunoassays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Radioimmunoassays Market Size by Application (2016-2027)
8.4 Asia-Pacific Radioimmunoassays Market Size by Region
8.4.1 Asia-Pacific Radioimmunoassays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Radioimmunoassays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Radioimmunoassays Market Size (2016-2027)
9.2 Latin America Radioimmunoassays Market Size by Type
9.2.1 Latin America Radioimmunoassays Market Size by Type (2016-2021)
9.2.2 Latin America Radioimmunoassays Market Size by Type (2022-2027)
9.2.3 Latin America Radioimmunoassays Market Size by Type (2016-2027)
9.3 Latin America Radioimmunoassays Market Size by Application
9.3.1 Latin America Radioimmunoassays Market Size by Application (2016-2021)
9.3.2 Latin America Radioimmunoassays Market Size by Application (2022-2027)
9.3.3 Latin America Radioimmunoassays Market Size by Application (2016-2027)
9.4 Latin America Radioimmunoassays Market Size by Country
9.4.1 Latin America Radioimmunoassays Market Size by Country (2016-2021)
9.4.2 Latin America Radioimmunoassays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Radioimmunoassays Market Size (2016-2027)
10.2 Middle East & Africa Radioimmunoassays Market Size by Type
10.2.1 Middle East & Africa Radioimmunoassays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Radioimmunoassays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Radioimmunoassays Market Size by Type (2016-2027)
10.3 Middle East & Africa Radioimmunoassays Market Size by Application
10.3.1 Middle East & Africa Radioimmunoassays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Radioimmunoassays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Radioimmunoassays Market Size by Application (2016-2027)
10.4 Middle East & Africa Radioimmunoassays Market Size by Country
10.4.1 Middle East & Africa Radioimmunoassays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Radioimmunoassays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Immunoshop India Pvt Ltd.
11.1.1 Immunoshop India Pvt Ltd. Company Details
11.1.2 Immunoshop India Pvt Ltd. Business Overview
11.1.3 Immunoshop India Pvt Ltd. Radioimmunoassays Introduction
11.1.4 Immunoshop India Pvt Ltd. Revenue in Radioimmunoassays Business (2016-2021)
11.1.5 Immunoshop India Pvt Ltd. Recent Development
11.2 Institute Of Isotopes Co. Ltd
11.2.1 Institute Of Isotopes Co. Ltd Company Details
11.2.2 Institute Of Isotopes Co. Ltd Business Overview
11.2.3 Institute Of Isotopes Co. Ltd Radioimmunoassays Introduction
11.2.4 Institute Of Isotopes Co. Ltd Revenue in Radioimmunoassays Business (2016-2021)
11.2.5 Institute Of Isotopes Co. Ltd Recent Development
11.3 Instrumentation Laboratory Co.
11.3.1 Instrumentation Laboratory Co. Company Details
11.3.2 Instrumentation Laboratory Co. Business Overview
11.3.3 Instrumentation Laboratory Co. Radioimmunoassays Introduction
11.3.4 Instrumentation Laboratory Co. Revenue in Radioimmunoassays Business (2016-2021)
11.3.5 Instrumentation Laboratory Co. Recent Development
11.4 Novartis Vaccines & Diagnostics Inc.
11.4.1 Novartis Vaccines & Diagnostics Inc. Company Details
11.4.2 Novartis Vaccines & Diagnostics Inc. Business Overview
11.4.3 Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Introduction
11.4.4 Novartis Vaccines & Diagnostics Inc. Revenue in Radioimmunoassays Business (2016-2021)
11.4.5 Novartis Vaccines & Diagnostics Inc. Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Details
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Radioimmunoassays Introduction
11.5.4 Sysmex Revenue in Radioimmunoassays Business (2016-2021)
11.5.5 Sysmex Recent Development
11.6 Trinity Biotech Plc
11.6.1 Trinity Biotech Plc Company Details
11.6.2 Trinity Biotech Plc Business Overview
11.6.3 Trinity Biotech Plc Radioimmunoassays Introduction
11.6.4 Trinity Biotech Plc Revenue in Radioimmunoassays Business (2016-2021)
11.6.5 Trinity Biotech Plc Recent Development
11.7 Weifang 3v Bioengineering Group Co. Ltd.
11.7.1 Weifang 3v Bioengineering Group Co. Ltd. Company Details
11.7.2 Weifang 3v Bioengineering Group Co. Ltd. Business Overview
11.7.3 Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Introduction
11.7.4 Weifang 3v Bioengineering Group Co. Ltd. Revenue in Radioimmunoassays Business (2016-2021)
11.7.5 Weifang 3v Bioengineering Group Co. Ltd. Recent Development
11.8 Weifang Kanghua Biotech Co. Ltd.
11.8.1 Weifang Kanghua Biotech Co. Ltd. Company Details
11.8.2 Weifang Kanghua Biotech Co. Ltd. Business Overview
11.8.3 Weifang Kanghua Biotech Co. Ltd. Radioimmunoassays Introduction
11.8.4 Weifang Kanghua Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2016-2021)
11.8.5 Weifang Kanghua Biotech Co. Ltd. Recent Development
11.9 Abbott Diagnostics
11.9.1 Abbott Diagnostics Company Details
11.9.2 Abbott Diagnostics Business Overview
11.9.3 Abbott Diagnostics Radioimmunoassays Introduction
11.9.4 Abbott Diagnostics Revenue in Radioimmunoassays Business (2016-2021)
11.9.5 Abbott Diagnostics Recent Development
11.10 Acon Laboratories Inc.
11.10.1 Acon Laboratories Inc. Company Details
11.10.2 Acon Laboratories Inc. Business Overview
11.10.3 Acon Laboratories Inc. Radioimmunoassays Introduction
11.10.4 Acon Laboratories Inc. Revenue in Radioimmunoassays Business (2016-2021)
11.10.5 Acon Laboratories Inc. Recent Development
11.11 Amar Immunodiagnostics
11.11.1 Amar Immunodiagnostics Company Details
11.11.2 Amar Immunodiagnostics Business Overview
11.11.3 Amar Immunodiagnostics Radioimmunoassays Introduction
11.11.4 Amar Immunodiagnostics Revenue in Radioimmunoassays Business (2016-2021)
11.11.5 Amar Immunodiagnostics Recent Development
11.12 Bayer Ag
11.12.1 Bayer Ag Company Details
11.12.2 Bayer Ag Business Overview
11.12.3 Bayer Ag Radioimmunoassays Introduction
11.12.4 Bayer Ag Revenue in Radioimmunoassays Business (2016-2021)
11.12.5 Bayer Ag Recent Development
11.13 Beckman Coulter Inc.
11.13.1 Beckman Coulter Inc. Company Details
11.13.2 Beckman Coulter Inc. Business Overview
11.13.3 Beckman Coulter Inc. Radioimmunoassays Introduction
11.13.4 Beckman Coulter Inc. Revenue in Radioimmunoassays Business (2016-2021)
11.13.5 Beckman Coulter Inc. Recent Development
11.14 Xiamen Boson Biotech Co. Ltd.
11.14.1 Xiamen Boson Biotech Co. Ltd. Company Details
11.14.2 Xiamen Boson Biotech Co. Ltd. Business Overview
11.14.3 Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Introduction
11.14.4 Xiamen Boson Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2016-2021)
11.14.5 Xiamen Boson Biotech Co. Ltd. Recent Development
11.15 Jei Daniel Biotech Corp.
11.15.1 Jei Daniel Biotech Corp. Company Details
11.15.2 Jei Daniel Biotech Corp. Business Overview
11.15.3 Jei Daniel Biotech Corp. Radioimmunoassays Introduction
11.15.4 Jei Daniel Biotech Corp. Revenue in Radioimmunoassays Business (2016-2021)
11.15.5 Jei Daniel Biotech Corp. Recent Development
11.16 Labor Diagnostika Nord Gmbh & Co. Kg
11.16.1 Labor Diagnostika Nord Gmbh & Co. Kg Company Details
11.16.2 Labor Diagnostika Nord Gmbh & Co. Kg Business Overview
11.16.3 Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Introduction
11.16.4 Labor Diagnostika Nord Gmbh & Co. Kg Revenue in Radioimmunoassays Business (2016-2021)
11.16.5 Labor Diagnostika Nord Gmbh & Co. Kg Recent Development
11.17 Micropoint Bioscience Inc.
11.17.1 Micropoint Bioscience Inc. Company Details
11.17.2 Micropoint Bioscience Inc. Business Overview
11.17.3 Micropoint Bioscience Inc. Radioimmunoassays Introduction
11.17.4 Micropoint Bioscience Inc. Revenue in Radioimmunoassays Business (2016-2021)
11.17.5 Micropoint Bioscience Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Radioimmunoassays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Balance Method
Table 3. Key Players of Sequential Saturation Method
Table 4. Global Radioimmunoassays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Radioimmunoassays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Radioimmunoassays Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Radioimmunoassays Market Share by Regions (2016-2021)
Table 8. Global Radioimmunoassays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Radioimmunoassays Market Share by Regions (2022-2027)
Table 10. Radioimmunoassays Market Trends
Table 11. Radioimmunoassays Market Drivers
Table 12. Radioimmunoassays Market Challenges
Table 13. Radioimmunoassays Market Restraints
Table 14. Global Radioimmunoassays Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Radioimmunoassays Market Share by Players (2016-2021)
Table 16. Global Top Radioimmunoassays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunoassays as of 2020)
Table 17. Ranking of Global Top Radioimmunoassays Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Radioimmunoassays Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Radioimmunoassays Product Solution and Service
Table 21. Date of Enter into Radioimmunoassays Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radioimmunoassays Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Radioimmunoassays Revenue Market Share by Type (2016-2021)
Table 25. Global Radioimmunoassays Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Radioimmunoassays Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Radioimmunoassays Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Radioimmunoassays Revenue Market Share by Application (2016-2021)
Table 29. Global Radioimmunoassays Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Radioimmunoassays Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Radioimmunoassays Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Radioimmunoassays Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Radioimmunoassays Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Radioimmunoassays Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Radioimmunoassays Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Radioimmunoassays Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Radioimmunoassays Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Radioimmunoassays Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Radioimmunoassays Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Radioimmunoassays Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Radioimmunoassays Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Radioimmunoassays Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Radioimmunoassays Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Radioimmunoassays Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Radioimmunoassays Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Radioimmunoassays Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Radioimmunoassays Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Radioimmunoassays Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Radioimmunoassays Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Radioimmunoassays Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Radioimmunoassays Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Radioimmunoassays Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Radioimmunoassays Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Radioimmunoassays Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Radioimmunoassays Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Radioimmunoassays Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Radioimmunoassays Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Radioimmunoassays Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Radioimmunoassays Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Radioimmunoassays Market Size by Country (2022-2027) & (US$ Million)
Table 61. Immunoshop India Pvt Ltd. Company Details
Table 62. Immunoshop India Pvt Ltd. Business Overview
Table 63. Immunoshop India Pvt Ltd. Radioimmunoassays Product
Table 64. Immunoshop India Pvt Ltd. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 65. Immunoshop India Pvt Ltd. Recent Development
Table 66. Institute Of Isotopes Co. Ltd Company Details
Table 67. Institute Of Isotopes Co. Ltd Business Overview
Table 68. Institute Of Isotopes Co. Ltd Radioimmunoassays Product
Table 69. Institute Of Isotopes Co. Ltd Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 70. Institute Of Isotopes Co. Ltd Recent Development
Table 71. Instrumentation Laboratory Co. Company Details
Table 72. Instrumentation Laboratory Co. Business Overview
Table 73. Instrumentation Laboratory Co. Radioimmunoassays Product
Table 74. Instrumentation Laboratory Co. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 75. Instrumentation Laboratory Co. Recent Development
Table 76. Novartis Vaccines & Diagnostics Inc. Company Details
Table 77. Novartis Vaccines & Diagnostics Inc. Business Overview
Table 78. Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Product
Table 79. Novartis Vaccines & Diagnostics Inc. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 80. Novartis Vaccines & Diagnostics Inc. Recent Development
Table 81. Sysmex Company Details
Table 82. Sysmex Business Overview
Table 83. Sysmex Radioimmunoassays Product
Table 84. Sysmex Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 85. Sysmex Recent Development
Table 86. Trinity Biotech Plc Company Details
Table 87. Trinity Biotech Plc Business Overview
Table 88. Trinity Biotech Plc Radioimmunoassays Product
Table 89. Trinity Biotech Plc Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 90. Trinity Biotech Plc Recent Development
Table 91. Weifang 3v Bioengineering Group Co. Ltd. Company Details
Table 92. Weifang 3v Bioengineering Group Co. Ltd. Business Overview
Table 93. Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Product
Table 94. Weifang 3v Bioengineering Group Co. Ltd. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 95. Weifang 3v Bioengineering Group Co. Ltd. Recent Development
Table 96. Weifang Kanghua Biotech Co. Ltd. Company Details
Table 97. Weifang Kanghua Biotech Co. Ltd. Business Overview
Table 98. Weifang Kanghua Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 99. Weifang Kanghua Biotech Co. Ltd. Recent Development
Table 100. Abbott Diagnostics Company Details
Table 101. Abbott Diagnostics Business Overview
Table 102. Abbott Diagnostics Radioimmunoassays Product
Table 103. Abbott Diagnostics Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 104. Abbott Diagnostics Recent Development
Table 105. Acon Laboratories Inc. Company Details
Table 106. Acon Laboratories Inc. Business Overview
Table 107. Acon Laboratories Inc. Radioimmunoassays Product
Table 108. Acon Laboratories Inc. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 109. Acon Laboratories Inc. Recent Development
Table 110. Amar Immunodiagnostics Company Details
Table 111. Amar Immunodiagnostics Business Overview
Table 112. Amar Immunodiagnostics Radioimmunoassays Product
Table 113. Amar Immunodiagnostics Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 114. Amar Immunodiagnostics Recent Development
Table 115. Bayer Ag Company Details
Table 116. Bayer Ag Business Overview
Table 117. Bayer Ag Radioimmunoassays Product
Table 118. Bayer Ag Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 119. Bayer Ag Recent Development
Table 120. Beckman Coulter Inc. Company Details
Table 121. Beckman Coulter Inc. Business Overview
Table 122. Beckman Coulter Inc. Radioimmunoassays Product
Table 123. Beckman Coulter Inc. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 124. Beckman Coulter Inc. Recent Development
Table 125. Xiamen Boson Biotech Co. Ltd. Company Details
Table 126. Xiamen Boson Biotech Co. Ltd. Business Overview
Table 127. Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Product
Table 128. Xiamen Boson Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 129. Xiamen Boson Biotech Co. Ltd. Recent Development
Table 130. Jei Daniel Biotech Corp. Company Details
Table 131. Jei Daniel Biotech Corp. Business Overview
Table 132. Jei Daniel Biotech Corp. Radioimmunoassays Product
Table 133. Jei Daniel Biotech Corp. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 134. Jei Daniel Biotech Corp. Recent Development
Table 135. Labor Diagnostika Nord Gmbh & Co. Kg Company Details
Table 136. Labor Diagnostika Nord Gmbh & Co. Kg Business Overview
Table 137. Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Product
Table 138. Labor Diagnostika Nord Gmbh & Co. Kg Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 139. Labor Diagnostika Nord Gmbh & Co. Kg Recent Development
Table 140. Micropoint Bioscience Inc. Company Details
Table 141. Micropoint Bioscience Inc. Business Overview
Table 142. Micropoint Bioscience Inc. Radioimmunoassays Product
Table 143. Micropoint Bioscience Inc. Revenue in Radioimmunoassays Business (2016-2021) & (US$ Million)
Table 144. Micropoint Bioscience Inc. Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioimmunoassays Market Share by Type: 2020 VS 2027
Figure 2. Balance Method Features
Figure 3. Sequential Saturation Method Features
Figure 4. Global Radioimmunoassays Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical Case Studies
Figure 6. Medical Testing Case Studies
Figure 7. Onology Case Studies
Figure 8. Others Case Studies
Figure 9. Radioimmunoassays Report Years Considered
Figure 10. Global Radioimmunoassays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Radioimmunoassays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Radioimmunoassays Market Share by Regions: 2020 VS 2027
Figure 13. Global Radioimmunoassays Market Share by Regions (2022-2027)
Figure 14. Global Radioimmunoassays Market Share by Players in 2020
Figure 15. Global Top Radioimmunoassays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunoassays as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Radioimmunoassays Revenue in 2020
Figure 17. Global Radioimmunoassays Revenue Market Share by Type (2016-2021)
Figure 18. Global Radioimmunoassays Revenue Market Share by Type (2022-2027)
Figure 19. North America Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Radioimmunoassays Market Share by Type (2016-2027)
Figure 21. North America Radioimmunoassays Market Share by Application (2016-2027)
Figure 22. North America Radioimmunoassays Market Share by Country (2016-2027)
Figure 23. United States Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Radioimmunoassays Market Share by Type (2016-2027)
Figure 27. Europe Radioimmunoassays Market Share by Application (2016-2027)
Figure 28. Europe Radioimmunoassays Market Share by Country (2016-2027)
Figure 29. Germany Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Radioimmunoassays Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Radioimmunoassays Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Radioimmunoassays Market Share by Region (2016-2027)
Figure 39. China Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Radioimmunoassays Market Share by Type (2016-2027)
Figure 47. Latin America Radioimmunoassays Market Share by Application (2016-2027)
Figure 48. Latin America Radioimmunoassays Market Share by Country (2016-2027)
Figure 49. Mexico Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Radioimmunoassays Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Radioimmunoassays Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Radioimmunoassays Market Share by Country (2016-2027)
Figure 55. Turkey Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Radioimmunoassays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Immunoshop India Pvt Ltd. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 59. Institute Of Isotopes Co. Ltd Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 60. Instrumentation Laboratory Co. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 61. Novartis Vaccines & Diagnostics Inc. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 62. Sysmex Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 63. Trinity Biotech Plc Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 64. Weifang 3v Bioengineering Group Co. Ltd. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 65. Weifang Kanghua Biotech Co. Ltd. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 66. Abbott Diagnostics Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 67. Acon Laboratories Inc. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 68. Amar Immunodiagnostics Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 69. Bayer Ag Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 70. Beckman Coulter Inc. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 71. Xiamen Boson Biotech Co. Ltd. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 72. Jei Daniel Biotech Corp. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 73. Labor Diagnostika Nord Gmbh & Co. Kg Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 74. Micropoint Bioscience Inc. Revenue Growth Rate in Radioimmunoassays Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed